TrialClinical and vaccine immunology : CVI2015

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.

Frank Struyf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.